Aspiriant LLC’s Berkshire Hathaway Class B BRK.B Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,500
Closed -$729K 299
2025
Q2
$729K Buy
+1,500
New +$762K 0.02% 171
2025
Q1
Sell
-1,000
Closed -$453K 290
2024
Q4
$453K Hold
1,000
0.02% 196
2024
Q3
$460K Sell
1,000
-1,000
-50% -$442K 0.02% 192
2024
Q2
$814K Buy
2,000
+1,000
+100% +$409K 0.03% 155
2024
Q1
$421K Hold
1,000
0.02% 212
2023
Q4
$357K Buy
+1,000
New +$351K 0.02% 223

Other funds holding BRK.B

Aspiriant LLC's BRK.B Position: Q2 2026 in Review

Aspiriant LLC reduced its Berkshire Hathaway Class B (BRK.B) stake by 1.5% in Q2 2026, selling an estimated $517K and leaving 72,942 shares worth $36.5M. The position accounts for 0.9% of the portfolio, ranked #18.

Aspiriant LLC first reported a position in BRK.B in Q2 2013 and has held it in 53 quarters since. The position peaked at $48.8M in Q1 2014. 1,715 funds tracked by Wall St. Rank hold BRK.B as of Q2 2026.

  • Aspiriant LLC held 72,942 shares of Berkshire Hathaway Class B worth $36.5M as of Q2 2026.
  • Aspiriant LLC sold 1,076 Berkshire Hathaway Class B shares in Q2 2026, an estimated $517K.
  • Berkshire Hathaway Class B made up 0.9% of Aspiriant LLC's portfolio in Q2 2026, its #18 holding.
  • Aspiriant LLC first reported a position in Berkshire Hathaway Class B in Q2 2013 and has held it in 53 quarters since.
  • Aspiriant LLC's Berkshire Hathaway Class B position peaked at $48.8M in Q1 2014.
  • 1,715 funds tracked by Wall St. Rank held Berkshire Hathaway Class B as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.